Researchers are exploring a new mRNA delivery technique to treat genetic conditions in the fetal brain, potentially ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...

Moderna shares rebound after six days of losses. Analysts mixed on stock with Strong Sell rating but potential for future growth.

Prenatal gene therapy via mRNA LNPs fixes faulty genes in fetal brain cells in animal model of neurodevelopmental syndrome.

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.

Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Montréal and UK-based startup Epitopea has raised $31 million USD ($43 million CAD) in what it called pre-Series A funding ...

According to an infectious disease expert, Hong Kong’s flu season is expected to start in December; it is likely to have two ...

The science behind vaccines is based on the fundamental principle of training the immune system to recognize and fight ...